A Study of LY3437943 in Healthy Participants With a High Body Mass Index
Part of paid clinical trials in Daytona Beach, Florida.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT05959096
- Phase
- PHASE1
- Status
- Completed
Conditions
- Healthy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Accepted
Interventions
- LY3437943 — DRUGAdministered SC
- LY3437943 — DRUGAdministered IV
Study Details
The study is conducted in two parts (Part A and B). The main purpose of this study is to look at the amount of the LY3437943 that gets into the blood stream and how long it takes the body to get rid of it when given subcutaneously (SC, under the skin) in the upper arm and thigh compared to the abdomen in healthy participants with high body mass index (BMI) in Part A. In Part B, the participants receive LY3437943 intravenously (IV, through a vein) where the safety and tolerability of LY3437943 are evaluated and information about any side effects experienced will be collected. For each participant, the total duration of the study will be approximately up to 157 days and 99 days for Part A and Part B, respectively.
Key Dates
- Start date
- Jul 18, 2023
- Status verified
- Sep 2024
- Primary completion
- Jul 25, 2024
- Completion
- Jul 25, 2024
Study Design
- Enrollment
- 85 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: LY3437943 (Part A)LY3437943 administered subcutaneously (SC) in either thigh, upper arm, or abdomen
- Experimental: LY3437943 (Part B)LY3437943 administered intravenously (IV)
Primary Outcome Measure
Part A: Pharmacokinetics (PK): Area Under the Plasma Concentration Versus Time Curve From Zero to Infinity (AUC[0-∞]) of LY3437943 [ Time Frame: Predose on Day 1 up to 43 days postdose (Part A) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Fortrea Clinical Research Unit | Daytona Beach | Florida | 32117 | - |
Find similar trials in Daytona Beach, FL
Related Studies
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated DonorsPHASE3 · Recruiting · Center for International Blood and Marrow Transplant Research · Boca Raton, Florida
- Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss OutcomeEnrolling By Invitation · Mayo Clinic · Jacksonville, Florida
- Breathing & Blood PressureRecruiting · Florida State University · Tallahassee, Florida
- A Study of Renal Microvessel Imaging for Chronic Kidney DiseasePHASE2 · Enrolling By Invitation · Mayo Clinic · Jacksonville, Florida